Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Douglas A. McIntyre | Apr 28, 2008 at 5:49 PM EDT

Merck’s (MRK) Hopes Crushed

Merck (MRK) had high hopes for its cholesterol drug Cordaptive According to The Wall Street Journal, things did not work…

Douglas A. McIntyre | Apr 28, 2008 at 3:34 PM EDT

Pharmacy Benefit Managers Dominate Medical Earnings Tuesday (MHS, ESRX)

Pharmacy benefits managers Express Scripts Inc. (NASDAQ: ESRX) and MedcoHealth Solutions Inc. (NASDAQ: MHS) are both set to report earnings…

Douglas A. McIntyre | Apr 28, 2008 at 11:20 AM EDT

Bristol-Myers Squibb Files Open Shelf Registration (BMY)

Bristol-Myers Squibb (NYSE: BMY) has submitted an open shelf offering today for an undetermined amount. The offering includes a combination…

Douglas A. McIntyre | Apr 24, 2008 at 3:15 PM EDT

Amgen’s (AMGN) Modest Quarter

Amgen (AMGN) adjusted earnings per share of $1.12 for the first quarter of 2008, an increase of 4 % compared…

Douglas A. McIntyre | Apr 24, 2008 at 7:03 AM EDT

Bristol-Myers Plans Partial Spin-Off of Nutritional Unit in IPO (BMY)

Bristol-Myers Squibb Company (NYSE: BMY) came out with earnings at $0.35 EPS and reaffirmed 2008 guidance of $1.36 to $1.46…

Douglas A. McIntyre | Apr 23, 2008 at 11:55 AM EDT

Biotech Business Daily (BIIB, GSK, ILMN, IVGN, LJPC, SIRT, STEM)

Biogen Idec (NASDAQ: BIIB) is sliding marginally despite reported earnings today that showed a 23% increase in earnings riding on…

Douglas A. McIntyre | Apr 23, 2008 at 5:34 AM EDT

FDA, Short On Funds Can’t Look For Deadly Drugs

The FDA says it needs $70 million to inspect all of the foreign facilities it needs to so it can…

Douglas A. McIntyre | Apr 22, 2008 at 4:07 PM EDT

Sirtris Major Buyout Premium From GlaxoSmithKline, Public Under a Year (SIRT, GSK)

GlaxoSmithKline (NYSE: GSK) has announced that it has entered into a definitive acquisition pact with Sirtris Pharmaceuticals Inc. (NASDAQ: SIRT).…

Douglas A. McIntyre | Apr 21, 2008 at 11:54 AM EDT

Biotech Business Daily (AMLN, CERS, LLY, DNA, GTOP, IMCL)

Amylin Pharmaceuticals (NASDAQ: AMLN) reported first quarter losses of $68.8 million, or $0.51 EPS, wider than the $49.4 million in…

Douglas A. McIntyre | Apr 18, 2008 at 11:12 AM EDT

IPO FILING: Epocrates Inc. (EPOC)

Epocrates Inc. submitted an SEC filing to come public via an IPO Thursday night. The filing shows a proposed maximum…

Douglas A. McIntyre | Apr 17, 2008 at 1:12 PM EDT

Inuitive Surgical Earnings To Set Stock Status (ISRG)

After today’s close, we’ll see earnings out of Intuitive Surgical, Inc. (NASDAQ: ISRG). The estimates for the DaVinci robotic surgical…

Douglas A. McIntyre | Apr 16, 2008 at 3:52 PM EDT

AVANT Scores Pfizer Pact For Brain Cancer (AVAN, PFE)

Pfizer, Inc (NYSE: PFE) has signed an agreement with the much smaller AVANT Immunotherapeutics (NASDAQ: AVAN). The two have announced…

Douglas A. McIntyre | Apr 16, 2008 at 3:37 PM EDT

Gilead Sciences… The Beat Goes On (GILD)

Gilead Sciences, Inc. (NASDAQ: GILD) posted results after the close today. Its Q1 revenues surged to $1.26 billion and non-GAAP…

Douglas A. McIntyre | Apr 16, 2008 at 1:03 PM EDT

Picking Apart Gilead Ahead of Earnings (GILD)

After today’s close, we’ll get to see earnings out of Gilead Sciences Inc. (NASDAQ: GILD). The estimates for the biopharmaceutical…

Douglas A. McIntyre | Apr 16, 2008 at 11:18 AM EDT

Biotech Busine$$ Daily (ACAD, AMLN, CVTX, HALO, KOSN, MCU, NVAX, POZN, REGN, SIRT)

If you thought biotech news was getting quiet going into earnings season, think again. Acadia Pharmaceuticals Inc. (ACAD) presents Phase…

1 … 352 353 354 355 356 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Merck’s (MRK) Hopes Crushed

Pharmacy Benefit Managers Dominate Medical Earnings Tuesday (MHS, ESRX)

Bristol-Myers Squibb Files Open Shelf Registration (BMY)

Amgen’s (AMGN) Modest Quarter

Bristol-Myers Plans Partial Spin-Off of Nutritional Unit in IPO (BMY)

Biotech Business Daily (BIIB, GSK, ILMN, IVGN, LJPC, SIRT, STEM)

FDA, Short On Funds Can’t Look For Deadly Drugs

Sirtris Major Buyout Premium From GlaxoSmithKline, Public Under a Year (SIRT, GSK)

Biotech Business Daily (AMLN, CERS, LLY, DNA, GTOP, IMCL)

IPO FILING: Epocrates Inc. (EPOC)

Inuitive Surgical Earnings To Set Stock Status (ISRG)

AVANT Scores Pfizer Pact For Brain Cancer (AVAN, PFE)

Gilead Sciences… The Beat Goes On (GILD)

Picking Apart Gilead Ahead of Earnings (GILD)

Biotech Busine$$ Daily (ACAD, AMLN, CVTX, HALO, KOSN, MCU, NVAX, POZN, REGN, SIRT)

Nvidia, Micron or Broadcom: What Would Raymond Dalio Do?

VGT Puts 39 Cents of Every Dollar Into Just 3 Stocks. The Pairing That Fixes It Without Selling

IRMAA Surprise: How Your 401(k) Distribution Today Triggers Medicare Surcharges Two Years Later

IRMAA Surprise: How Your 401(k) Distribution Today Triggers Medicare Surcharges Two Years Later

He Needs $30,000 for a Roof and Furnace at 69. A New Maine Law Could Help Him Borrow Without Making More of His Social Security Taxable.

Nvidia, Micron or Broadcom: What Would Raymond Dalio Do?

VGT Puts 39 Cents of Every Dollar Into Just 3 Stocks. The Pairing That Fixes It Without Selling

Health and Healthcare Articles

All Health and Healthcare Articles

Merck’s (MRK) Hopes Crushed

Pharmacy Benefit Managers Dominate Medical Earnings Tuesday (MHS, ESRX)

Bristol-Myers Squibb Files Open Shelf Registration (BMY)

Amgen’s (AMGN) Modest Quarter

Bristol-Myers Plans Partial Spin-Off of Nutritional Unit in IPO (BMY)

Biotech Business Daily (BIIB, GSK, ILMN, IVGN, LJPC, SIRT, STEM)

FDA, Short On Funds Can’t Look For Deadly Drugs

Sirtris Major Buyout Premium From GlaxoSmithKline, Public Under a Year (SIRT, GSK)

Biotech Business Daily (AMLN, CERS, LLY, DNA, GTOP, IMCL)

IPO FILING: Epocrates Inc. (EPOC)

Inuitive Surgical Earnings To Set Stock Status (ISRG)

AVANT Scores Pfizer Pact For Brain Cancer (AVAN, PFE)

Gilead Sciences… The Beat Goes On (GILD)

Picking Apart Gilead Ahead of Earnings (GILD)

Biotech Busine$$ Daily (ACAD, AMLN, CVTX, HALO, KOSN, MCU, NVAX, POZN, REGN, SIRT)

Nvidia, Micron or Broadcom: What Would Raymond Dalio Do?

VGT Puts 39 Cents of Every Dollar Into Just 3 Stocks. The Pairing That Fixes It Without Selling

IRMAA Surprise: How Your 401(k) Distribution Today Triggers Medicare Surcharges Two Years Later

Featured Reads

IRMAA Surprise: How Your 401(k) Distribution Today Triggers Medicare Surcharges Two Years Later

He Needs $30,000 for a Roof and Furnace at 69. A New Maine Law Could Help Him Borrow Without Making More of His Social Security Taxable.